Climb Bio Inc Earnings

The next earnings date for Climb Bio Inc is March 9, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Climb Bio Inc Earnings

Report Date	Estimated Earnings Per Share
03/09/2026	$-0.16

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Climb Bio Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/18/2025	---	$-0.19	-29.52%
08/12/2025	---	$-0.13	---
11/13/2024	---	$-0.13	---
08/14/2024	---	$-1.81	---
05/13/2024	---	$-0.06	---
03/04/2024	---	$-0.13	---
11/06/2023	---	$-0.15	---
09/11/2023	---	$-0.19	---
05/12/2023	---	$-0.84	---
03/07/2023	---	$-0.29	---
11/14/2022	---	$-0.37	---
08/15/2022	---	$-0.56	---
05/16/2022	---	$-0.50	---
03/08/2022	---	$-0.40	---
11/09/2021	---	$-0.42	---
09/14/2021	---	$-0.41	---

More About Climb Bio Inc

Website

https://climbbio.com

Country

USA

Full Time Employees

Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN). The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.

“Climb Bio Inc Earnings” Can Refer to the Climb Bio Inc Earnings Date

Some people say “Climb Bio Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Climb Bio Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Climb Bio Inc Stock on the Earnings Date

If you own Climb Bio Inc stock (CLYM) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Climb Bio Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Climb Bio Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Climb Bio Inc Earnings

You can contact us any time if you would like to ask questions about Climb Bio Inc earnings or anything else related to the stock market.